Brain Imaging of Nicotinic Receptors in Alzheimer's Disease

Abstract EN

Neuronal nicotinic acetylcholine receptors (nAChRs) are a family of ligand-gated ion channels which are widely distributed in the human brain.

Several lines of evidence suggest that two major subtypes (α4β2 and α7) of nAChRs play an important role in the pathophysiology of Alzheimer's disease (AD).

Postmortem studies demonstrated alterations in the density of these subtypes of nAChRs in the brain of patients with AD.

Currently, nAChRs are one of the most attractive therapeutic targets for AD.

Therefore, several researchers have made an effort to develop novel radioligands that can be used to study quantitatively the distribution of these two subtypes in the human brain with positron emission tomography (PET) and single-photon emission computed tomography (SPECT).

In this paper, we discuss the current topics on in vivo imaging of two subtypes of nAChRs in the brain of patients with AD.